References

Sanquin EBL outgrowth

1. Akker et.al. The majority of the in vitro erythroid expansion potential resides in CD34(−) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica, 2010 Sep. 95 (9), 1594–1598. [Pubmed]

2. Heideveld et.al. CD14+ cells from peripheral blood positively regulate hematopoietic stem and progenitor cell survival resulting in increased erythroid yield. Haematologica, 2015 Nov. 100 (11), 1396–1406. [Pubmed]

3. Heshusius et.al. Large-scale in vitro production of red blood cells from human peripheral blood mononuclear cells. Blood Adv. 2019 Nov 12;3(21):3337-3350. [Pubmed]

Sanquin iPSC differentiation and reviews

4. Hansen et.al. Human-induced pluripotent stem cell-derived blood products: state of the art and future directions. FEBS Lett. 2019 Sep 14. [Pubmed]

5. Hansen, Varga, Aarts et.al. Efficient production of erythroid, megakaryocytic and myeloid cells, using single cell-derived iPSC colony differentiation. Stem Cell Res. 2018 May;29:232-244. [Pubmed]

6. Varga, Hansen et.al. Erythropoiesis and Megakaryopoiesis in a Dish. IntechOpen, November 5th 2018, Book chapter [Reference Link]

Sanquin iPSC lines

7. Hansen et.al. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts. Stem Cell Res. 2017 Jan;18:26-28. [Pubmed]

8. Hansen, Varga et.al. Generation and characterization of human iPSC lines SANi001-A and SANi002-A from mobilized peripheral blood derived megakaryoblasts. Stem Cell Res. 2017 Dec;25:42-45. [Pubmed]

9. Hansen, Varga et.al. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B. Stem Cell Res. 2017 Dec;25:34-37. [Pubmed]

10. Varga, Hansen et.al. Generation of human erythroblast-derived iPSC line using episomal reprogramming system. Stem Cell Res. 2017 Dec;25:30-33. [Pubmed]

Selected publication using iPSC lines derived at Sanquin

11. Mandoli et.al. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs. Cell Rep. 2016 Nov 15;17(8):2087-2100. [Pubmed]

12. Oorschot et.al. Molecular mechanisms of bleeding disorder associated GFI1BQ287* mutation and its affected pathways in megakaryocytes and platelets. Haematologica. 2019 Jul;104(7):1460-1472. [Pubmed]

13. Theil et.al. Trichothiodystrophy causative TFIIEβ mutation affects transcription in highly differentiated tissue. Hum Mol Genet. 2017 Dec 1;26(23):4689-4698. [Pubmed]

14. Yi et.al. CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1. Blood Cancer J. 2019 Mar 8;9(3):33. [Pubmed]

Others

15. Chou et.al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011 Mar. 21(3), 518–529. [Pubmed]

16. Chou et.al. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach. Stem Cells Transl Med. 2015 Apr;4(4):320-32. [Pubmed]

17. Nishimura et.al. Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem. 2011 Feb 11;286(6):4760-71. [Pubmed]

18. Voelkel et.al. Protein transduction from retroviral Gag precursors. Proc. Natl.
Acad. Sci. U. S. A. 2010, 107 (17), 7805–7810. [Pubmed]

19. Warlich et.al. 2011. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol. Ther. 2011, 19 (4), 782–789. [Pubmed]

Contact

Questions or want to order?

ipsc.facility@sanquin.nl